Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
7 New Drugs for Primary Care: Q2 2019
The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about? Click through to find out.
At the close of the second quarter, Patient Care has compiled a list of 7 new FDA-approved drugs for conditions that are often seen in primary care. Below you will find details on the first generic version of Narcan®--naloxone hydrochloride nasal spray for opioid overdose; the first and only topical lotion that combines halobetasol propionate and tazarotene for the treatment of plaque psoriasis; plus 5 more.
Recent Videos
Related Content
